ArticlePharmacology research & perspectives2024

Population pharmacokinetic modeling of vedolizumab for graft-versus-host disease prophylaxis in adults with allogeneic hematopoietic stem cell transplant.

Timothy Waterhouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.